Your browser doesn't support javascript.
loading
Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells.
Rodríguez-Ubreva, Javier; Català-Moll, Francesc; Obermajer, Natasa; Álvarez-Errico, Damiana; Ramirez, Ricardo N; Company, Carlos; Vento-Tormo, Roser; Moreno-Bueno, Gema; Edwards, Robert P; Mortazavi, Ali; Kalinski, Pawel; Ballestar, Esteban.
Afiliação
  • Rodríguez-Ubreva J; Chromatin and Disease Group, Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address: jrubreva@idibell.cat.
  • Català-Moll F; Chromatin and Disease Group, Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
  • Obermajer N; Department of Surgery and Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15213, USA.
  • Álvarez-Errico D; Chromatin and Disease Group, Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
  • Ramirez RN; Department of Developmental and Cell Biology, University of California, Irvine, CA 92697, USA.
  • Company C; Chromatin and Disease Group, Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
  • Vento-Tormo R; Chromatin and Disease Group, Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
  • Moreno-Bueno G; Departamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas "Alberto Sols" (CSIC-UAM), IdiPAZ, CIBERONC, 28029 Madrid, Spain; Fundación MD Anderson International, 28033 Madrid, Spain.
  • Edwards RP; Magee-Womens Research Institute Ovarian Cancer Center of Excellence, Peritoneal/Ovarian Cancer Specialty Care Center, and University of Pittsburgh Cancer Institute, University of Pittsburgh, Hillman Cancer Center, Pittsburgh, PA 15213, USA.
  • Mortazavi A; Department of Developmental and Cell Biology, University of California, Irvine, CA 92697, USA.
  • Kalinski P; Department of Surgery and Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15213, USA; Department of Medicine and Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
  • Ballestar E; Chromatin and Disease Group, Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address: eballestar@idibell.cat.
Cell Rep ; 21(1): 154-167, 2017 Oct 03.
Article em En | MEDLINE | ID: mdl-28978469
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Dinoprostona / Regulação Neoplásica da Expressão Gênica / DNA (Citosina-5-)-Metiltransferases / Células Supressoras Mieloides / Tolerância Imunológica Limite: Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Dinoprostona / Regulação Neoplásica da Expressão Gênica / DNA (Citosina-5-)-Metiltransferases / Células Supressoras Mieloides / Tolerância Imunológica Limite: Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article